In the last quarterly (released about 18 days ago?) they said GLP tox studies would commence Q4 2022, the language suggested it was yet to begin.
Slide 16 of this presentation; "GLP toxicology studies (rodents, NHPs) have commenced."
Great to see this update on their progress towards getting the DX1 program to the clinic and/or partnered up.
Ann: Chairman's Address and CEO Presentation to 2022 AGM, page-2
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $16.46M | |||
| Open | High | Low | Value | Volume |
| 0.8¢ | 0.8¢ | 0.8¢ | $5.395K | 674.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 19 | 5603441 | 0.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.8¢ | 478105 | 1 |
View Market Depth
| Last trade - 16.10pm 09/05/2024 (20 minute delay) ? |
|
|||||
|
Last
0.8¢ |
Change
0.000 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 0.8¢ | 0.8¢ | 0.8¢ | 75272 | ||
| Last updated 14.06pm 09/05/2024 ? | |||||
| PAB (ASX) Chart |